Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$14.28 - $19.53 $367,552 - $502,682
-25,739 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$12.99 - $20.47 $14,470 - $22,803
1,114 Added 4.52%
25,739 $382,000
Q2 2021

Aug 16, 2021

SELL
$15.46 - $24.5 $39.3 Million - $62.3 Million
-2,541,393 Reduced 99.04%
24,625 $492,000
Q1 2021

May 14, 2021

BUY
$19.33 - $37.75 $11.8 Million - $23 Million
609,716 Added 31.17%
2,566,018 $59.2 Million
Q4 2020

Feb 02, 2021

BUY
$24.48 - $42.47 $10.9 Million - $19 Million
447,294 Added 29.64%
1,956,302 $48.3 Million
Q3 2020

Nov 05, 2020

BUY
$39.09 - $53.44 $27.4 Million - $37.4 Million
700,492 Added 86.64%
1,509,008 $62.6 Million
Q2 2020

Jul 22, 2020

BUY
$46.7 - $92.04 $11.8 Million - $23.3 Million
253,076 Added 45.56%
808,516 $38.7 Million
Q1 2020

May 06, 2020

SELL
$48.35 - $118.68 $10.8 Million - $26.6 Million
-224,109 Reduced 28.75%
555,440 $35 Million
Q4 2019

Feb 03, 2020

SELL
$57.36 - $124.1 $5.91 Million - $12.8 Million
-103,036 Reduced 11.67%
779,549 $96.6 Million
Q3 2019

Nov 04, 2019

SELL
$58.69 - $80.46 $12.4 Million - $16.9 Million
-210,523 Reduced 19.26%
882,585 $58.6 Million
Q2 2019

Jul 30, 2019

BUY
$77.77 - $120.68 $14.9 Million - $23.1 Million
191,132 Added 21.19%
1,093,108 $87 Million
Q1 2019

May 09, 2019

SELL
$91.83 - $120.68 $7.3 Million - $9.59 Million
-79,507 Reduced 8.1%
901,976 $101 Million
Q4 2018

Feb 07, 2019

SELL
$85.79 - $126.46 $9.51 Million - $14 Million
-110,836 Reduced 10.15%
981,483 $98.9 Million
Q3 2018

Oct 25, 2018

BUY
$88.49 - $127.55 $22.3 Million - $32.1 Million
251,735 Added 29.95%
1,092,319 $138 Million
Q2 2018

Aug 02, 2018

BUY
$60.0 - $85.67 $1.34 Million - $1.91 Million
22,310 Added 2.73%
840,584 $70.5 Million
Q1 2018

Apr 23, 2018

BUY
$52.72 - $67.25 $11.2 Million - $14.3 Million
212,820 Added 35.15%
818,274 $50.3 Million
Q4 2017

Feb 08, 2018

BUY
$58.2 - $72.76 $17.8 Million - $22.2 Million
304,999 Added 101.51%
605,454 $35.4 Million
Q3 2017

Oct 24, 2017

BUY
$57.01 - $118.75 $17.1 Million - $35.7 Million
300,455
300,455 $17.4 Million

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.